Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Graphene oxide and indole-3-acetic acid together inhibit root growth in Brassica napus L. by affecting multiple plant hormone pathways.

Alefacept showed some effectiveness for alopecia areata but needs more research.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

Traction may not be the only cause of cicatricial marginal alopecia.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Many skin patients also have mental health issues, and doctors should treat both together.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

More research is needed to determine if iron deficiency causes hair loss.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Aging makes hair thinner and rougher, with less clear edges.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

The BMP2 gene is more active in the early growth phase of Cashmere goat hair and may affect hair regeneration and textile production.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Early surgical treatment for severe facial injuries from high-energy impacts leads to better recovery.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

The 3D structure of a key hair protein was modeled, revealing specific helical structures and stabilization features.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.